MedPath

Effectiveness of Clonidine for the treatment of sciatica: A randomized, double-blind and prospective study. (EFFOC study)

Conditions
Radicular lumbar pain
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Registration Number
EUCTR2011-003560-74-NL
Lead Sponsor
eiden University Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Patients with lumbar radicular pain and NRS > 4 for longer than 6 weeks
MRI evidence of a herniated disc

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 20
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 20

Exclusion Criteria

Obesity (BMI > 40)
Coagulopathy
Use of anticoagulation
Systemic or local infection
Allergy to local anesthetics, clonidine or steroids
Legal claims or workman’s compensation
Pregnancy
FBSS
Transforaminal epidural steroid injections or (pulsed) radiofrequency treatment at lumbar nerve roots within one year before inclusion in the study

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: 1)To study the effect of Clonidine on lumbar radicular pain with a transforaminal epidural injection after 1 week, 1, 3 and 6 months using a BPI.;Secondary Objective: 2)To study the effect of Clonidine on lumbar radicular pain with a transforaminal epidural injection after 1 week, 1, 3 and 6 months using the Ostwestry index;Primary end point(s): 1. Brief Pain Inventory (BPI)<br>2. Ostwestry Disability Questionnaire <br>;Timepoint(s) of evaluation of this end point: 1 hour post-intervention<br>1 week post-intervention<br>1 month post-intervention<br>3 months post-intervention<br>6 months post-intervention<br>
Secondary Outcome Measures
NameTimeMethod
Secondary end point(s): Ostwestry Index;Timepoint(s) of evaluation of this end point: 1 hour post-intervention<br>1 week post-intervention<br>1 month post-intervention<br>3 moonths post-intervention<br>6 months post-intervention
© Copyright 2025. All Rights Reserved by MedPath